Page 3 - Stephen Hytha News Today

Shares of Zogenix Inc. rose by 66% after the company reported it entered into an agreement to be acquired by UCB. S.A. of Belgium for $26.00 per share in cash. The offer includes the potential for an additional $2.00 per share if a specific drug approval milestone is met.

Gritstone bio Inc.s lower-dose samRNA vaccines include a broader immune response to SARS-CoV-2 and may provide better protection against emerging variants.

Micron Technology Inc. shares traded 11% higher after the company reported Q1/22 financial results and stated that it was on a path toward record revenue.

CMC Materials Inc. shares traded 33% higher after the semiconductor materials company reported it agreed to be acquired by Entegris Inc. in a combination cash and stock deal valued at approximately $6.5 billion.

Shares of Great Bear Resources Ltd. traded 24% higher after the company reported it entered into a definitive agreement to be acquired by Kinross Gold for CA$1.8 billion. Existing Great Bear shareholders will be given the option of receiving CA$29.00 per share in cash, shares in Kinross or a pro-rata combination of both, plus a contingent value right.

Enphase Energy Inc. shares traded 27% higher after the company reported Q3/21 financial results that included a nearly 97% increase in YoY revenue.

Bloom Energy Corp. shares traded 37% higher after the company reported it is significantly expanding its partnership with SK ecoplant of South Korea to establish a market leadership position in the hydrogen economy.

Emerita Resources Corp. shares traded near 15% higher after the company reported step-out drill results from a hole at its La Infanta project in Spain that returned 8.2 m of 2.5% Cu, 17.3% Zn, 8.7% Pb, 223.5 g/t Ag, 0.5 g/t Au. Clarus Securities advised in research note Friday that it is maintaining its Speculative Buy rating and CA$4.50/share price target for Emeritas (EMO) shares and stated it sees significant resource expansion potential for the IBW property.

Shares of Radius Health Inc. traded 17% higher after the firm reported positive topline results from the Phase 3 EMERALD study of elacestrant in ER+/HER2- advanced or metastatic breast cancer (mBC).

NaturalShrimp Inc.s shares traded 12% higher after the company reported it entered into an agreement with Gulf Seafood Inc. for delivery of 25,000 lbs. of naturally grown, chemical and antibiotic-free, live shrimp.